AbbVie: Macular Edema trials

The registry lists 32 Macular Edema studies with AbbVie as lead sponsor. 0 are open to participants now and 24 have results posted.

Phase 1 2Phase 2 6Phase 3 7Phase 4 4No phase 14(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study to Evaluate an Updated Dexamethasone Intravitreal (Into the Eye) Applicator in Adult Participants With Macular Edema Due to Diseases of the RetinaCompletedNCT04976777Phase 3Results posted
• Chart Review: Drug Utilization Study in Participants Who Received Ozurdex™ (Dexamethasone Intravitreal Implant) 0.7 mg Injections for Visual Impairment Due to Diabetic Macular Edema (DME)CompletedNCT03889444Results posted
• Retrospective Data Collection Study in Patients With Macular Oedema Receiving OZURDEX®CompletedNCT02181530Results posted
• A Safety and Efficacy Study of Dexamethasone Versus Laser Photocoagulation in Participants With Diabetic Macular EdemaCompletedNCT02121262Phase 3Results posted
• A Retrospective Study of Anti-Vascular Endothelial Growth Factor (VEGF) Injections for Retinal Vein Occlusion or Diabetic Macular EdemaCompletedNCT01918371Results posted
• A Safety and Efficacy Study of OZURDEX® in Macular Edema Associated With Branch Retinal Vein OcclusionCompletedNCT01903720Phase 4Results posted
• A Retrospective Chart Review of OZURDEX® in Patients With Macular EdemaCompletedNCT01805323Results posted
• Safety and Efficacy Study of Dexamethasone in the Treatment of Patients With Macular Edema Following Retinal Vein Occlusion (RVO)CompletedNCT01660802Phase 3Results posted
• Study of Ozurdex® Treatment Practice in Patients With Macular Oedema Due to Retinal Vein OcclusionCompletedNCT01618266Results posted
• A Safety and Efficacy Study to Assess OZURDEX® in Patients With Macular Oedema Secondary to Retinal Vein Occlusion (RVO)CompletedNCT01571557Results posted
• Post Market Surveillance of OZURDEX® for Branch Retinal Vein Occlusion (BRVO) and Central Retinal Vein Occlusion (CRVO)CompletedNCT01568021Results posted
• Retrospective Data Collection Study in Patients Receiving Two or More OZURDEX® Injections for Macular Oedema Secondary to Retinal Vein OcclusionCompletedNCT01566526Results posted
• Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular EdemaCompletedNCT01492400Phase 2Results posted
• A Retrospective Data Collection Study in Patients Receiving Dexamethasone Intravitreal Implant (Ozurdex®) for Macular Oedema Due to Retinal Vein Occlusion (RVO)CompletedNCT01445626Results posted
• Safety and Efficacy Study of Ozurdex® Compared to Lucentis® in Patients With Branch Retinal Vein OcclusionCompletedNCT01427751Phase 4Results posted
• Retrospective Study in Patients Receiving Two or More OZURDEX® Injections for Retinal Vein Occlusion (RVO)CompletedNCT01411696Results posted
• Study of MP0112 Intravitreal Injection in Patients With Diabetic Macular EdemaTerminatedNCT01042678Phase 1Results posted
• Safety and Efficacy of AGN208397 in the Treatment of Macular Edema Associated With Retinal Vein Occlusion (RVO)CompletedNCT01027650Phase 1/2Results posted
• Safety and Efficacy of a New Treatment in Vitrectomized Subjects With Diabetic Macular EdemaCompletedNCT00799227Phase 2Results posted
• Safety and Efficacy of a New Treatment in Combination With Laser for Diabetic Macular EdemaCompletedNCT00464685Phase 2Results posted
• A Study of the Safety and Efficacy of a New Treatment for Diabetic Macular EdemaCompletedNCT00168389Phase 3Results posted
• A Study of the Safety and Efficacy of a New Treatment for Diabetic Macular EdemaCompletedNCT00168337Phase 3Results posted
• A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein OcclusionCompletedNCT00168324Phase 3Results posted
• A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein OcclusionCompletedNCT00168298Phase 3Results posted
• A Study to Evaluate the Effectiveness and Safety of OZURDEX® in Patients With Diabetic Macular Edema But Never TreatedCompletedNCT03953807Phase 4
• Evaluation of OZURDEX® in Patients With Macular Edema Secondary to Retinal Vein Occlusion in ChinaCompletedNCT03908307Phase 4
• Efficacy of Ozurdex® in the Treatment of Diabetic Macular Edema (DME)CompletedNCT03003416
• Study of OZURDEX® in the Treatment of Diabetic Macular Oedema (DME) in Australia - The AUSSIEDEX StudyCompletedNCT02731911
• An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)CompletedNCT02188173
• A Study of Abicipar Pegol in Patients With Diabetic Macular EdemaCompletedNCT02186119Phase 2
• A Long-Term Safety Study of OZURDEX® in Clinical PracticeCompletedNCT01539577
• Research Study in Patients With Persistent Macular EdemaCompletedNCT00035906Phase 2